Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2024-04-16 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
第三届董事会第二十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by Nanjing Yaoshi Technology Co., Ltd. It details the decision made by the board regarding the non-adjustment of the convertible bond's conversion price. The text includes meeting attendance, voting results, and compliance with company law and articles of association. There is no financial data, no detailed report, no earnings or annual report content, and no mention of shareholder voting results beyond the board's internal decision. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2024-04-16 Chinese
关于药石转债可能触发向下修正转股价格条件的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from 南京药石科技股份有限公司 regarding a potential downward adjustment of the conversion price of its convertible bonds (药石转债). It details the bond issuance, listing, conversion price adjustment conditions, and the procedure for price adjustment. The document is a notification about a possible triggering event for price adjustment and the company's intended follow-up actions, rather than a financial report or detailed analysis. It is relatively short (3097 characters) and serves as a regulatory disclosure to inform investors about the bond's status and potential price adjustment. This fits the category of a Capital/Financing Update (CAP), as it relates to convertible bond terms and potential changes affecting capital structure and financing instruments.
2024-04-09 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, the price range, total amount spent, and compliance with regulatory requirements. It references the company's prior announcement of the repurchase plan and provides updates on the repurchase activity up to a specific date (March 31, 2024). The document is relatively short (1270 characters) and focuses on the ongoing status of share buybacks rather than financial results or other report types. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2024-04-01 Chinese
关于2024年第一季度可转债转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the conversion of convertible bonds into shares for the first quarter of 2024 by 南京药石科技股份有限公司. It details the bond issuance, conversion prices, conversion period, and the resulting changes in share capital. The document includes specific data on bond conversion amounts, share changes, and regulatory compliance references. It is not a full financial report but a regulatory announcement about bond conversion and share capital changes. The document length is 3029 characters, which is relatively short and focused on a specific capital/financing update rather than a full report or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-04-01 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company about the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with regulatory requirements. It references specific regulatory guidelines for share buybacks and provides updates on the repurchase activity up to a recent date. The document is not a full financial report, earnings release, or management discussion, but a specific update on share repurchase activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused solely on repurchase progress, confirming it is not a full report but an announcement of repurchase activity.
2024-03-01 Chinese
关于控股股东、实际控制人部分股份补充质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the supplementary pledge of shares by the controlling shareholder and actual controller of the company. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company capital, and confirms no change in control or significant impact on company operations. It includes tables of shareholding and pledge details and mentions related documents for reference. The content is focused on share pledging activities by a major shareholder, which is a capital structure update rather than a full financial report or management discussion. The document length is short (1496 characters) and it is not an announcement of a report publication but a direct disclosure of a share pledge event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-02-08 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.